In a talk at the 2017 National Institute of Drug Abuse meeting on June 17th, Dr Evan Wood pondered lessons learned and success tips derived from his
Double trouble: opioids and pain among people with substance use disorders
Against the use of opioids for chronic non-cancer pain to people who have active substance use disorders advises the third recommendation in the new
Two birds with one stone: physicians training in research
Combined training in addiction medicine and research is feasible and acceptable for physicians - a new study shows; however, there are important
Publication Impact of Addiction Clinician-Scientist Fellowship
This study evaluated the impact of an addiction medicine research fellowship. As such, the evaluation here has the potential to radically change
How can we do better job in studying Topiramate?
Topiramate prevents seizures in people with epilepsy. Previously, we looked at all studies to see whether Topiramate can help treat cocaine addiction,
What do persons on methadone in primary care think about alcohol screening?
Enhancing alcohol screening and brief intervention among people receiving opioid agonist treatment: Qualitative study in primary care New Paper Out
XXV Annual Meeting & Canadian Scientific Conference 2015 CSAM – SMCA (#WhatTheFentanyl #abhealth)
What is the future of addiction medicine? What is the future addiction specialist going to look like? Nobody knows what the future is going to look
AMERSA 39th Annual National Conference
November 5th, the national conference of the Association for Medical Education and Research in Addiction - AMERSA 39th - took place in Washington, DC.
Alcohol and Methadone Don’t Mix! What’s New in Addiction Medicine? lecture series
Please join us on Tuesday, October 27 for this month’s edition of the “What’s New in Addiction Medicine?” lecture series. This (free) event